Literature DB >> 24657574

Purine metabolite and energy charge analysis of Trypanosoma brucei cells in different growth phases using an optimized ion-pair RP-HPLC/UV for the quantification of adenine and guanine pools.

Patricia Graven1, Margherita Tambalo1, Leonardo Scapozza1, Remo Perozzo2.   

Abstract

Human African Trypanosomiasis (HAT) is caused by the protozoan parasite Trypanosoma brucei. Although trypanosomes are well-studied model organisms, only little is known about their adenine and guanine nucleotide pools. Besides being building blocks of RNA and DNA, these nucleotides are also important modulators of diverse biochemical cellular processes. Adenine nucleotides also play an important role in the regulation of metabolic energy. The energetic state of cells is evaluated by the energy charge which gives information about how much energy is available in form of high energy phosphate bonds of adenine nucleotides. A sensitive and reproducible ion-pair RP-HPLC/UV method was developed and optimized, allowing the quantification of guanine and adenine nucleosides/nucleotides in T. brucei. With this method, the purine levels and their respective ratios were investigated in trypanosomes during logarithmic, stationary and senescent growth phases. Results of this study showed that all adenine and guanine purines under investigation were in the low mM range. The energy charge was found to decrease from logarithmic to static and to senescent phase whereas AMP/ATP, ADP/ATP and GDP/GTP ratios increased in the same order. In addition, the AMP/ATP ratio varied as the square of the ADP/ATP ratio, indicating AMP to be the key energy sensor molecule in trypanosomes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Energy charge; Growth phases; HPLC; Purine pool; Trypanosoma brucei

Mesh:

Substances:

Year:  2014        PMID: 24657574     DOI: 10.1016/j.exppara.2014.03.006

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  6 in total

1.  The AMPKα1 Pathway Positively Regulates the Developmental Transition from Proliferation to Quiescence in Trypanosoma brucei.

Authors:  Manuel Saldivia; Gloria Ceballos-Pérez; Jean-Mathieu Bart; Miguel Navarro
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

2.  Detection of Guanine and Adenine Using an Aminated Reduced Graphene Oxide Functional Membrane-Modified Glassy Carbon Electrode.

Authors:  Di Li; Xiao-Lu Yang; Bao-Lin Xiao; Fang-Yong Geng; Jun Hong; Nader Sheibani; Ali Akbar Moosavi-Movahedi
Journal:  Sensors (Basel)       Date:  2017-07-18       Impact factor: 3.576

3.  The kinetic characteristics of human and trypanosomatid phosphofructokinases for the reverse reaction.

Authors:  Peter M Fernandes; James Kinkead; Iain W McNae; Frédéric Bringaud; Paul A M Michels; Malcolm D Walkinshaw
Journal:  Biochem J       Date:  2019-01-18       Impact factor: 3.857

4.  Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids.

Authors:  Diego Benítez; Andrea Medeiros; Lucía Fiestas; Esteban A Panozzo-Zenere; Franziska Maiwald; Kyriakos C Prousis; Marina Roussaki; Theodora Calogeropoulou; Anastasia Detsi; Timo Jaeger; Jonas Šarlauskas; Lucíja Peterlin Mašič; Conrad Kunick; Guillermo R Labadie; Leopold Flohé; Marcelo A Comini
Journal:  PLoS Negl Trop Dis       Date:  2016-04-12

5.  Structures of Leishmania Fructose-1,6-Bisphosphatase Reveal Species-Specific Differences in the Mechanism of Allosteric Inhibition.

Authors:  Meng Yuan; Montserrat G Vásquez-Valdivieso; Iain W McNae; Paul A M Michels; Linda A Fothergill-Gilmore; Malcolm D Walkinshaw
Journal:  J Mol Biol       Date:  2017-09-04       Impact factor: 5.469

6.  Kinetic and structural studies of Trypanosoma and Leishmania phosphofructokinases show evolutionary divergence and identify AMP as a switch regulating glycolysis versus gluconeogenesis.

Authors:  Peter M Fernandes; James Kinkead; Iain W McNae; Monserrat Vásquez-Valdivieso; Martin A Wear; Paul A M Michels; Malcolm D Walkinshaw
Journal:  FEBS J       Date:  2020-01-08       Impact factor: 5.542

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.